GILEAD SCIENCES, INC. — Director's Dealing 2014

Dec 24, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2014-12-22

Reporting Person: Cogan John Francis (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-12-22	Common Stock	M	26000	$14.3375	Acquired	68405	Direct
2014-12-22	Common Stock	S	5650	$93.1762	Disposed	62755	Direct
2014-12-22	Common Stock	S	5322	$94.1255	Disposed	57433	Direct
2014-12-22	Common Stock	S	5071	$94.9663	Disposed	52362	Direct
2014-12-22	Common Stock	S	6400	$96.2784	Disposed	45962	Direct
2014-12-22	Common Stock	S	3240	$97.0923	Disposed	42722	Direct
2014-12-22	Common Stock	S	317	$97.9136	Disposed	42405	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-12-22	Non-Qualified Stock Option (Right to Buy)	$14.3375	M	26000	Disposed	2016-05-10	Common Stock (26000)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: Options are 100% vested on the date of grant.

F3: Sale prices reported for the transactions reported here range from $92.60 to $93.59. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F4: Sale prices reported for the transactions reported here range from $93.65 to $94.61. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F5: Sale prices reported for the transactions reported here range from $94.66 to $95.64. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F6: Sale prices reported for the transactions reported here range from $95.69 to $96.68. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F7: Sale prices reported for the transactions reported here range from $96.69 to $97.68. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F8: Sale prices reported for the transactions reported here range from $97.91 to $97.92. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.